Submitted by dcc on Thu, 2017-02-16 13:44 Study Title: A Phase II/III Randomized Trial Of Veliparib Or Placebo In Combination With Adjuvant Temozolomide In Newly Diagnosed Glioblastoma With MGMT Promoter HypermethylationCIRB: Adult CIRB - Late Phase EmphasisLead Group: AllianceStatus: ActiveReview Status: Available to Open
